DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial 

DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trial 

Abstract Background Despite treatment with highly effective antimalarial drugs, malaria annually claims the lives of over half a million children under 5-years of age in sub-Saharan Africa. Cerebral malaria (CM), defined as Plasmodium falciparum infection with coma, is the severe malaria syndrome wi...

全面介紹

書目詳細資料
Main Authors: Nginache Nampota-Nkomba, Osward M. Nyirenda, Jane Mallewa, Yamikani Chimalizeni, Nettie Dzabala, Michael P. Fay, Mathangi Gopalakrishnan, Matthew B. Laurens, Nicole F. O’Brien, Louis H. Miller, Susan K. Pierce, Brittany A. Riggle, Douglas G. Postels
格式: Article
語言:English
出版: BMC 2024-01-01
叢編:Trials
主題:
6-Diazo-5-oxo-L-norleucine
DON
Glutamine antagonist
Cerebral malaria
Malaria
Plasmodium falciparum
在線閱讀:https://doi.org/10.1186/s13063-023-07808-w

因特網

https://doi.org/10.1186/s13063-023-07808-w

相似書籍